Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;7(1):35-42.
doi: 10.2215/CJN.04690511. Epub 2011 Nov 17.

Timing and determinants of erythropoietin deficiency in chronic kidney disease

Collaborators, Affiliations

Timing and determinants of erythropoietin deficiency in chronic kidney disease

Lucile Mercadal et al. Clin J Am Soc Nephrol. 2012 Jan.

Abstract

Background and objectives: Anemia in patients with CKD is highly related to impaired erythropoietin (EPO) response, the timing and determinants of which remain unknown.

Design, setting, participants, & measurements: This study measured EPO levels and studied their relation to GFR measured by 51Cr-EDTA renal clearance (mGFR) in 336 all-stage CKD patients not receiving any erythropoiesis-stimulating agent.

Results: In patients with anemia defined by World Health Organization criteria (hemoglobin [Hb] <13 g/dl in men and 12 g/dl in women), EPO response to Hb level varied by mGFR level. EPO and Hb levels were negatively correlated (r=-0.22, P=0.04) when mGFR was >30 ml/min per 1.73 m(2), whereas they were not correlated when mGFR was <30 (r=0.09, P=0.3; P for interaction=0.01). In patients with anemia, the ratio of observed EPO to the level predicted by the equation for their Hb level decreased from 0.72 (interquartile range, 0.57-0.95) for mGFR ≥60 ml/min per 1.73 m(2) to 0.36 (interquartile range, 0.16-0.69) for mGFR <15. Obesity, diabetes with nephropathy other than diabetic glomerulopathy, absolute iron deficiency, and high C-reactive protein concentrations were associated with increased EPO levels, independent of Hb and mGFR.

Conclusions: Anemia in CKD is marked by an early relative EPO deficiency, but several factors besides Hb may persistently stimulate EPO synthesis. Although EPO deficiency is likely the main determinant of anemia in patients with advanced CKD, the presence of anemia in those with mGFR >30 ml/min per 1.73 m(2) calls for other explanatory factors.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Relations between erythropoietin (log10) and hemoglobin (Hb) levels by anemia status according to the World Health Organization definition and measured GFR (mGFR) level. Open circles, nonanemic patients; solid circles, anemic patients.
Figure 2.
Figure 2.
Observed and predicted erythropoietin (EPO) by measured GFR (mGFR) levels in patients with anemia according to the World Health Organization definition.

References

    1. Goldwasser E, Kung CKH: Purification of erythropoietin. Proc Natl Acad Sci USA 68: 697–698, 1971 - PMC - PubMed
    1. Shoemaker CB, Mitsock LD: Murine erythropoietin gene: Cloning, expression, and human gene homology. Mol Cell Biol 6: 849–858, 1986 - PMC - PubMed
    1. Drüeke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A. CREATE Investigators: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071–2084, 2006 - PubMed
    1. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D. CHOIR Investigators: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085–2098, 2006 - PubMed
    1. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de Zeeuw D, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R. TREAT Investigators: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019–2032, 2009 - PubMed

Publication types